These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22086974)
1. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome. Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974 [TBL] [Abstract][Full Text] [Related]
2. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer. Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877 [TBL] [Abstract][Full Text] [Related]
3. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012 [TBL] [Abstract][Full Text] [Related]
4. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y; Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554 [TBL] [Abstract][Full Text] [Related]
5. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype. Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331 [TBL] [Abstract][Full Text] [Related]
6. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC). Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318 [TBL] [Abstract][Full Text] [Related]
7. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571 [TBL] [Abstract][Full Text] [Related]
8. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy. Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair. Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230 [TBL] [Abstract][Full Text] [Related]
10. A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay. Bianchi F; Maccaroni E; Belvederesi L; Brugiati C; Giampieri R; Bini F; Bracci R; Pagliaretta S; Del Prete M; Piva F; Mandolesi A; Scarpelli M; Berardi R Fam Cancer; 2018 Apr; 17(2):215-224. PubMed ID: 28785832 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer in an MSH2 gene mutation carrier. Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127 [TBL] [Abstract][Full Text] [Related]
12. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Chan TL; Yuen ST; Kong CK; Chan YW; Chan AS; Ng WF; Tsui WY; Lo MW; Tam WY; Li VS; Leung SY Nat Genet; 2006 Oct; 38(10):1178-83. PubMed ID: 16951683 [TBL] [Abstract][Full Text] [Related]
13. A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. Bianchi F; Galizia E; Porfiri E; Belvederesi L; Catalani R; Loretelli C; Bracci R; Bearzi I; Turchi C; Viel A; Cellerino R Fam Cancer; 2007; 6(1):97-102. PubMed ID: 17165155 [TBL] [Abstract][Full Text] [Related]
14. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic? Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549 [TBL] [Abstract][Full Text] [Related]
15. New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife. Medina-Arana V; Barrios Y; Fernández-Peralta A; Herrera M; Chinea N; Lorenzo N; Jiménez A; Martín-López JV; González-Hermoso F; Salido E; González-Aguilera JJ Cancer Lett; 2006 Dec; 244(2):268-73. PubMed ID: 16500024 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of pathogenicity in human MSH2 missense mutants. Ollila S; Dermadi Bebek D; Jiricny J; Nyström M Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462 [TBL] [Abstract][Full Text] [Related]
17. Functional analysis of HNPCC-related missense mutations in MSH2. Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302 [TBL] [Abstract][Full Text] [Related]
18. Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome. Menéndez M; Castellví-Bel S; Pineda M; de Cid R; Muñoz J; González S; Teulé A; Balaguer F; Ramón y Cajal T; Reñé JM; Blanco I; Castells A; Capellà G Clin Genet; 2010 Aug; 78(2):186-90. PubMed ID: 20095990 [TBL] [Abstract][Full Text] [Related]
19. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
20. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]